John Arthur

John is the Director of the Medicines Manufacturing Innovation Centre, Glasgow, a collaboration between CPI, University of Strathclyde, UK Research & Industry, Scottish Enterprise and founding industry partners, AstraZeneca and GSK.

The centre will ensure the UK is a technology and innovation leader in pharmaceutical manufacturing, thereby boosting the competitiveness of both sectors. The initial focus will be on technology translation for small molecule drug manufacture.

Prior to joining CPI in October 2019 John worked for GSK, joining the company in 1986 as a Process Chemist at the Worthing Site. During his time on Site he held roles covering all aspects of the manufacturing supply chain from large scale fermentation, fine chemicals (both chemical and enzymatic conversions), Chemical Development and Secondary Sterile Operations.

After 10 years of site base roles he was seconded to Head office to lead a workstream of a global supply restructuring programme. In 2000 he moved to the Irvine plant to lead the Development team and take change of the construction a new 300te nanomilling and spray drying plant. This period was followed with a number of roles working out of GSK House in strategic program leadership including Head of the Global Manufacturing & Supply Programme Management Office, 5 years in the Core Business Services Function (IT, Procurement and Real estate) as Head of PMO and finally back to manufacturing to Leader a Global manufacturing restructuring programme.

John has a BSc (Hons) in Chemistry, an MBA from Strathclyde University Business School, a Private Pilot’s license and double decker bus license.